Search clinical trials for: Loratadine

Total 137 results

Sandoz

Completed

To Demonstrate the Relative Bioavailability Study of Loratadine 10 mg Tablets

Allergy
Bayer

Completed

To Assess Bioequivalence of Loratadine Oral Solution/Syrup Versus Claritin Peach Syrup (Bordeaux)

Histamine H1 Antagonists, Non-Sedating

Germany
Xian-Janssen Pharmaceutical Ltd.

Completed

A Study to Assess the Bioequivalence of Xisimin (Loratadine) Tablets Under Fasting and Fed Conditions in Healthy Participants Compared With Clarityne Tablets

Healthy

China
Xian-Janssen Pharmaceutical Ltd.

Completed

A Study to Assess the Relative Bioavailability of Xisimin (Loratadine) Tablets Under Fasting and Fed Conditions in Healthy Participants Compared to Clarityne Tablets

Healthy

Taiwan
Andover Research Eye Institute

Completed

A Study Comparing the Efficacy of Pataday® Once Daily Relief Extra Strength to Claritin® Tablets 24-Hour in Subjects With Allergic Conjunctivitis

Allergic Conjunctivitis

United States
Bayer

Completed

A Study of Onset of Action of Loratadine and Fexofenadine in Participants With Seasonal Allergic Rhinitis (P08712)

Rhinitis
Merck Sharp & Dohme LLC

Completed

Observation of Use of Claritin (Loratadine) Tablet, RediTabs, and Dry Syrup in Children (Study P05834)(COMPLETED)

Rhinitis, Allergic, Perennial | Rhinitis, Allergic, Seasonal | Pruritus | Urticaria
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Loratadine Orally Disintegrating Tablets 10 mg Under Fed Conditions

Healthy
Thammasat University

Completed

Efficacy and Adverse Effects of Prapchompoothaweep Remedy and Loratadine for Treatment in AR Patients

Quality of Life | Allergic Rhinitis | Adverse Drug Event

Thailand
Bayer

Completed

A Study to Evaluate Cooling Sensation of an Allergy Product in Adults With a History of Allergies

Allergic Rhinitis

United States
Merck Sharp & Dohme LLC

Completed

Post Approval Pharmacokinetic Study of Loratadine in Japanese Pediatric and Adult Patients (Study P05539)

Perennial Allergic Rhinitis
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study on Loratadine Orally Disintegrating Tablets 10 mg Under Fasting Conditions

Healthy
ALK-Abelló A/S
Merck Sharp & Dohme LLC

Completed

Efficacy and Safety Study of SCH 900237/MK-8237 in Children and Adults With House Dust Mite-Induced Allergic Rhinitis/Rhinoconjunctivitis (P05607)

Rhinitis, Allergic, Perennial | Rhinitis, Allergic, Nonseasonal
Hangzhou Grand Biologic Pharmaceutical, Inc.

Not yet recruiting

Efficacy and Safety of Histamine Human Immunoglobulin in the Treatment of Chronic Spontaneous Urticaria (CSU)

Chronic Spontaneous Urticaria
Organon and Co

Completed

Montelukast in Seasonal Allergic Rhinitis - Fall 1999 Study (0476A-117)

Seasonal Allergic Rhinitis
Organon and Co

Completed

Montelukast in Patients With Seasonal Allergic Rhinitis - Spring 2000 Study (MK-0476A-162)(COMPLETED)

Seasonal Allergic Rhinitis
Sanofi

Recruiting

Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC)

Pruritus

Poland, Argentina, China, Spain, Italy, Japan, United States, Canada, France, Germany, Hungary, Korea, Republic of
Alcon Research

Completed

Study of Olopatadine HCl Ophthalmic Solutions Compared to Vehicle Using the Conjunctival Allergen Challenge (CAC) Model of Acute Allergic Conjunctivitis in Japanese Subjects

Allergic Conjunctivitis
Noha Mansour

Not yet recruiting

Novel Preventive Approach Against Filgrastim-Induced Bone Pain in Cancer Patients

Breast Cancer | Filgrastim Adverse Reaction
ALK-Abelló A/S

Completed

Efficacy and Safety of Grass Sublingual Tablet in Children and Adolescents (P05239 AM3)(COMPLETED)

Allergy | Rhinitis | Conjunctivitis | Rhinoconjunctivitis
Bayer

Completed

A Manufacturing Transfer Study Comparing the Bioequivalence of a Single Oral Dose of Claritin-D 12-Hour Extended Release Tablet From 2 Different Manufacturers Under Fasted Conditions in Healthy Adult Subjects

Clinical Pharmacology

United States
Alcon Research

Completed

Safety of PATANASE Nasal Spray in Patients With Perennial Allergic Rhinitis

Perennial Allergic Rhinitis

United States
Bayer

Completed

A Manufacturing Transfer Study Comparing the Bioequivalence of a Single Oral Dose of Claritin-D 12-Hour Extended Release Tablet From 2 Different Manufactuers Under Fed Conditions in Healthy Adult Subjects

Clinical Pharmacology

United States
Alcon Research

Completed

Olopatadine Hydrochloride Ophthalmic Solution Study in Chinese Subjects

Allergic Conjunctivitis
Peking Union Medical College Hospital

Unknown

Effectiveness of Qufeng Shengshi Fang on Treatment of Allergic Rhinitis.

Rhinitis, Allergic, Perennial

China
Alcon Research

Completed

Safety and Pharmacokinetics of Patanase in Pediatric Patients 2 to < 6 Years of Age

Allergic Rhinitis

United States
Alcon Research

Completed

Olopatadine 0.2% for the Treatment of Allergic Conjunctivitis

Allergic Conjunctivitis
Azidus Brasil

Withdrawn

Clinical Trial Of The Effectiveness Of The Product Cloratadd D (Loratadine + Pseudoephedrine Sulfate) Produced By The Laboratory EMS S/A, Compared To The Drug Claritin D Produced By Schering-Plough S/A, In Patients With Allergic Rhinitis

Allergic Rhinitis

Brazil
Organon and Co
Merck Sharp & Dohme LLC

Completed

Effects of Loratadine/Montelukast vs Pseudoephedrine and Placebo in Patients With Seasonal Allergic Rhinitis (Study P04095) (COMPLETED)

Rhinitis, Allergic, Seasonal
Organon and Co

Completed

A Study Investigating the Effect of Montelukast in Patients With Seasonal Allergic Rhinitis (MK-0476-192)(COMPLETED)

Seasonal Allergic Rhinitis
Organon and Co

Completed

Montelukast in Seasonal Allergic Rhinitis - Spring 2001 Study (0476-235)

Seasonal Allergic Rhinitis
Innovacion y Desarrollo de Estrategias en Salud
National Institute of Pediatrics, Mexico; Laboratorios Senosiain, S.A. de C.V.

Completed

Montelukast and Loratadine in Children With Asthma

Asthma in Children
Azidus Brasil
EMS S/A

Completed

Effectiveness of Two Preparations of Loratadine + Pseudoephedrine in Patients With Perennial Allergic Rhinitis.

Perennial Allergic Rhinitis

Brazil
ALK-Abelló A/S

Completed

Efficacy and Safety of Grass Sublingual Tablet in Adults (P05238 AM3)(COMPLETED)

Allergy | Rhinitis | Conjunctivitis | Rhinoconjunctivitis
Organon and Co

Completed

Effect of Loratadine/Montelukast Combination on Congestion in SAR Patients Exposed to Pollen in an EEU (Study P04822)

Seasonal Allergic Rhinitis
Organon and Co

Completed

Montelukast in Seasonal Allergic Rhinitis: Fall 2001 Study (0476-240)

Seasonal Allergic Rhinitis
Organon and Co

Completed

A Study to Evaluate the Safety of Combination Montelukast/Loratadine in Mexican Participants With Allergic Rhinitis (MK-0476A-484)

Allergic Rhinitis
Bayer
Queen's University

Completed

A Randomized, Placebo Controlled Study to Determine the Efficacy and Speed of a Nasal Spray in Allergen Induced Seasonal Allergic Rhinitis (GEYSER)

Seasonal Allergic Rhinitis

Canada
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Loratadine / Pseudoephedrine Sulfate 10/ 240 mg Extended-Release Tablets Under Fed Conditions

Healthy

Canada
Zalicus

Completed

A Phase I Study to Assess the Safety and Tolerability of Topical CRx-197 Formulations in Healthy Volunteers

Atopic Dermatitis

Germany
Alcon Research

Completed

Efficacy and Safety of an Ophthalmic Solution in Patients With Allergic Conjunctivitis

Allergic Conjunctivitis
MEDA Pharma GmbH & Co. KG

Completed

MP-AzeFlu Allergen Chamber - Onset of Action Study

Seasonal Allergic Rhinitis

Canada
University of Turin, Italy
Regione Piemonte

Completed

Iron Repletion in Chronic Cough and Iron Deficiency (CID)

Cough | Iron Deficiency | Laryngeal Disease | Bronchial Disease

Italy
Ranbaxy Laboratories Limited

Completed

Bioequivalnce Study of Loratadine / Pseudoephedrine Sulfate 10/ 240 mg Extended-Release Tablets Under Fasting Conditions

Healthy

Canada
AHS Cancer Control Alberta

Not yet recruiting

Loratadine for the Prevention of G-CSF-related Bone Pain

Stem Cell Transplant Complications

Canada
Merck Sharp & Dohme LLC

Completed

Efficacy and Safety Study of RAGWITEK™ (MK-3641) in Children With Ragweed-Induced Rhinoconjunctivitis With or Without Asthma (MK-3641-008)

Rhinitis, Allergic, Seasonal
Wake Forest University Health Sciences

Completed

Evaluation of Loratadine for G-CSF Induced Bone Pain in Patients With Hematologic Malignancies

Lymphoma | Leukemia

United States
Alcon Research

Completed

Safety and Comfort of AL-4943A Ophthalmic Solution

Allergic Conjunctivitis
University of Vermont
Cancer and Leukemia Group B

Unknown

Evaluation of Loratadine for Prevention of Pegfilgrastim-Induced Pain

Pegfilgrastim-induced Back and Leg Pain

United States
Allergan

Completed

Safety and Efficacy of Olopatadine Hydrochloride/Ketorolac Tromethamine Ophthalmic Solution Compared With Olopatadine Hydrochloride Ophthalmic Solution in Patients With Seasonal Allergic Conjunctivitis

Rhinitis, Allergic, Seasonal | Conjunctivitis, Allergic

India

3

Subscribe